» Articles » PMID: 27030004

Cutaneuos Findings in Patients with Predialysis Chronic Kidney Disease

Overview
Date 2016 Apr 1
PMID 27030004
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several cutaneous findings are seen in dialysis dependent chronic kidney disease (CKD) patients. However, there are only a few small studies on cutaneous findings in predialysis CKD patients. We aimed to determine cutaneous findings in predialysis CKD patients.

Methods: This was a cross-sectional study. Consecutive predialysis CKD patients from nephrology outpatient clinic in a university affiliated hospital were recruited to this study. Detailed dermatologic examination was performed by a senior dermatologist. Blood urea, creatinine, hepatitis B surface antigen and hepatitis C antibody test were studied for each participant.

Results: A total of 365 consecutive predialysis CKD patients (stages 2-5) included in the study. Three hundred and fifty-eight patients (98.1%) had at least one dermatologic finding. The most common cutaneous finding was xerosis (64.9%) followed by hair findings (41.4%), pruritus (19.2%), pigmentary changes (17.5%), nail findings (15.3%) and oral mucosal findings (9.3%). Longitudinal striations was the most common nail finding, diffuse brown hyperpigmentation was the most common pigmentary change, coated tongue was the most common oral mucosal finding and androgenetic alopecia was the most common hair finding. Frequency and diversity of dermatologic findings did not change across CKD stages.

Conclusions: This is the largest study investigating dermatologic findings in a well-characterized predialysis CKD patient population. We found that at least one cutaneous finding was present in almost all of the CKD patients. Cutaneous findings are very common and diverse among predialysis CKD patients.

Citing Articles

Quality of life and clinical data in hemodialysis patients with different degrees of pruritus.

Fontao S, Manso P, Audije-Gil J, Hernan Gascuena D, Dapena F, Areste N Sci Rep. 2025; 15(1):6222.

PMID: 39979317 PMC: 11842785. DOI: 10.1038/s41598-024-83833-2.


Atopic dermatitis and chronic kidney disease: a bidirectional Mendelian randomization study.

Zhang H, Yuan S, Li Y, Li D, Yu Z, Hu L Front Med (Lausanne). 2023; 10:1180596.

PMID: 37441684 PMC: 10333750. DOI: 10.3389/fmed.2023.1180596.


Recognizing skin conditions in patients with cirrhosis: a narrative review.

Liu Y, Zhao Y, Gao X, Liu J, Ji F, Hsu Y Ann Med. 2022; 54(1):3017-3029.

PMID: 36308406 PMC: 9629063. DOI: 10.1080/07853890.2022.2138961.


Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.

Querfeld U, Mak R, Pries A Clin Sci (Lond). 2020; 134(12):1333-1356.

PMID: 32542397 PMC: 7298155. DOI: 10.1042/CS20200279.


The relationship between dermatological findings and serum interleukin 31 and serum uridine diphosphate glucose ceramide glucosyltransferase levels among patients with chronic kidney disease.

Guvercin B, Kaynar K, Arica D, Kural B, Ulusoy S, Cansiz M Hippokratia. 2020; 23(2):75-80.

PMID: 32265588 PMC: 7127917.